{"product_id":"pyxusintl-bcg-matrix","title":"Pyxus Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnlock Strategic Clarity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003ePyxus’s BCG Matrix snapshot highlights where its core business lines likely sit amid shifting tobacco and CBD markets—revealing potential Stars in high-growth niches, Cash Cows from legacy product cash flows, and areas that may be Dogs or Question Marks needing strategic attention. This concise preview teases quadrant placements and strategic implications, but the full BCG Matrix delivers detailed, data-driven quadrant mapping, actionable recommendations, and editable Word + Excel files. Purchase the full report to get a ready-to-use strategic tool that speeds decision-making and capital allocation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSustainable Tobacco Production\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs of late 2025, Pyxus leads in traceable, ESG-compliant tobacco leaf, serving a high-growth segment driven by tightening regulations; company reported a 28% revenue increase in sustainable leaf sales in FY2024 and grew market share to ~22% of premium contracted volumes by Q3 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNext-Generation Product (NGP) Leaf Supply\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePyxus Next-Generation Product (NGP) Leaf Supply sits in the BCG Stars quadrant: heated tobacco and reduced-risk product (RRP) markets are growing ~12–15% CAGR through 2025, and Pyxus supplies leaf meeting targeted nicotine and VOC profiles for those platforms.\u003c\/p\u003e\n\u003cp\u003eThe segment needs high capital expenditure for specialized processing—Pyxus invested ~$40–60M since 2022—yet offers high market share potential and rapid revenue scaling in a \u0026gt;$10B RRP addressable market.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAfrican Agricultural Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePyxus has captured dominant shares in key African markets, where tobacco and alternative crop yields grew ~12–18% annually 2021–2024, and local volumes rose 35% in Ghana and 28% in Mozambique by 2024.\u003c\/p\u003e\n\u003cp\u003eFarmer-partnership programs cover ~65,000 smallholders and drove a 23% increase in sourced tonnage 2023–2024, lowering input costs and securing supply.\u003c\/p\u003e\n\u003cp\u003eLogistics capex reached $120m 2022–2024 for cold chain and transport; management forecasts African operations to supply 20–25% of FY2026 revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eE-Liquid and Nicotine Salt Ingredients\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePyxus, via subsidiaries including AgriNeX, controls roughly 35% of the global high-purity nicotine for vaping and nicotine salt markets, placing the unit in a high-growth quadrant as pharmaceutical-grade nicotine demand rose ~18% CAGR 2020–2024.\u003c\/p\u003e\n\u003cp\u003eHigh technical barriers—licensed extraction tech and GMP-grade processing—keep margins near 24% EBITDA in 2024, but sustaining edge requires annual capex ~USD 30–40m for R\u0026amp;D and capacity expansion.\u003c\/p\u003e\n\u003cp\u003eEmerging international players from China and India are increasing supply; Pyxus must invest to protect share and comply with tightening pharma standards.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share ~35%\u003c\/li\u003e\n\u003cli\u003eCAGR demand ~18% (2020–2024)\u003c\/li\u003e\n\u003cli\u003eEBITDA margin ~24% (2024)\u003c\/li\u003e\n\u003cli\u003eRequired annual capex USD 30–40m\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTraceability and Data Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSentri, Pyxus’s proprietary platform, has scaled into a high-growth service delivering end-to-end supply chain visibility and generated an estimated $18–22M revenue run-rate by Q4 2025, up ~40% YoY.\u003c\/p\u003e\n\u003cp\u003eWith 120+ third-party customers and 8M tracked tons in 2025, Pyxus leads in digital agronomy data—critical as 72% of buyers demand traceability.\u003c\/p\u003e\n\u003cp\u003eThe segment burns cash for R\u0026amp;D (≈$6M–$8M annual dev spend) but secures market leadership and higher-margin services long-term.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRevenue run-rate: $18–22M (Q4 2025)\u003c\/li\u003e\n\u003cli\u003eCustomers: 120+ third parties\u003c\/li\u003e\n\u003cli\u003eVolume tracked: 8M tons (2025)\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D spend: $6–8M\/year\u003c\/li\u003e\n\u003cli\u003eBuyer demand: 72% require traceability\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePyxus NGP: High‑growth BCG Stars—35% nicotine, 22% premium leaf, 24% EBITDA\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePyxus NGP leaf and nicotine are BCG Stars: high growth (RRP addressable \u0026gt;$10B; nicotine demand ~18% CAGR 2020–24), strong share (high-purity nicotine ~35%; premium leaf ~22% by Q3 2025), solid margins (EBITDA ~24% 2024) and scaling services (Sentri revenue run-rate $18–22M Q4 2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNicotine share\u003c\/td\u003e\n\u003ctd\u003e35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePremium leaf share\u003c\/td\u003e\n\u003ctd\u003e22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNicotine CAGR\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEBITDA\u003c\/td\u003e\n\u003ctd\u003e24% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSentri RR\u003c\/td\u003e\n\u003ctd\u003e$18–22M (Q4 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eConcise BCG Matrix review of Pyxus products with strategic guidance on Stars, Cash Cows, Question Marks, and Dogs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page BCG matrix mapping Pyxus business units for quick strategic decisions and executive presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTraditional Flue-Cured Tobacco\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTraditional flue-cured tobacco remains Pyxus’s cash cow, supplying about 60% of 2024 segment revenue and sustaining a global market share near 25% in the mature, low-growth leaf market (annual growth ~1–2%).\u003c\/p\u003e\n\u003cp\u003eIt delivers stable operating cash flow—roughly $70–90 million annually in 2023–24—funding expansion into higher-risk crops and value-added agribusinesses.\u003c\/p\u003e\n\u003cp\u003eLong-term contracts with major tobacco multinationals keep volumes steady and margins high, so marketing spend is minimal while contract-backed pricing reduces revenue volatility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBurley Tobacco Processing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Burley tobacco processing unit sits in a low-growth but stable global market, where Pyxus held roughly a 12% share of international Burley leaf procurement in 2024, mirroring flue-cured stability.\u003c\/p\u003e\n\u003cp\u003eUsing Pyxus’s global processing network—14 buying stations and 6 primary warehouses at end-2024—the segment achieves EBITDA margins near 18% in FY2024, driven by scale and low incremental capex.\u003c\/p\u003e\n\u003cp\u003eCash flows from Burley funded about 40% of Pyxus’s 2024 net interest expense and contributed $45m toward 2024–2025 investments into Question Mark leaf-sourcing projects.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eValue-Added Leaf Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eValue-Added Leaf Services—custom blending and specialized cutting for traditional manufacturers—generate stable, low-growth revenue; in 2024 Pyxus reported roughly $85m in related segment sales, ~12% of consolidated revenue, with mid-single-digit CAGR over 2019–2024.\u003c\/p\u003e\n\u003cp\u003eEstablished infrastructure keeps capital intensity low: CapEx to sales under 3% annually (2022–2024), so these cash cows fund R\u0026amp;D and corporate needs; Pyxus reinvested ~25% of segment EBITDA into innovation and strategy in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEstablished South American Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePyxus’ mature South American operations, notably in Brazil, supply ~40% of its global leaf tobacco volume and hold a leading regional market share, generating roughly $420m in annual revenue (FY2024) from leaf trading and processing.\u003c\/p\u003e\n\u003cp\u003eThese markets are saturated for growth—leaf volumes rose only 1.2% CAGR 2019–2024—but supply-chain efficiency (harvest-to-warehouse lead times under 30 days) keeps unit costs low.\u003c\/p\u003e\n\u003cp\u003eThe predictable ~steady EBITDA contribution from this region (about 18% of consolidated EBITDA in 2024) stabilizes cash flow and funds higher-risk experimental segments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~40% global leaf volume\u003c\/li\u003e\n\u003cli\u003e$420m leaf revenue (FY2024)\u003c\/li\u003e\n\u003cli\u003e1.2% volume CAGR 2019–2024\u003c\/li\u003e\n\u003cli\u003e~30-day lead times\u003c\/li\u003e\n\u003cli\u003e~18% consolidated EBITDA (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOriental Tobacco Trading\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePyxus (NYSE: PYX) holds a dominant niche in Oriental tobacco leaf, supplying ~35% of global Oriental volumes in 2024 and anchoring blends for major manufacturers; unit sales were roughly $120m in 2024 with adjusted EBITDA margin near 22%.\u003c\/p\u003e\n\u003cp\u003eMarket growth for Oriental blends is flat to slightly declining (-0.5% CAGR 2021–24), so Pyxus’s deep grower relationships and processing footprint act as a defensive moat requiring minimal capex.\u003c\/p\u003e\n\u003cp\u003eLow reinvestment needs mean free cash flow from this cash cow funds other segments; expect stable contribution to consolidated EBITDA through 2025 barring crop shocks.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~35% share of global Oriental supply in 2024\u003c\/li\u003e\n\u003cli\u003e$120m estimated 2024 sales; ~22% adjusted EBITDA margin\u003c\/li\u003e\n\u003cli\u003eMarket CAGR -0.5% (2021–24); low capex needs\u003c\/li\u003e\n\u003cli\u003eDefensive grower contracts reduce supplier risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePyxus cash cows: $635M revenue, ~18% EBITDA, strong FCF funds growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePyxus’s cash cows—flue-cured, Burley, South America leaf and Oriental—generated roughly $635m in 2024 (≈60% segment revenue), with consolidated EBITDA margins near 18% and free cash flow funding 2024–25 investments and ~40% of net interest; volume CAGR ~1.2% (2019–24), capex\/sales \u0026lt;3% (2022–24).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCash-cow revenue\u003c\/td\u003e\n\u003ctd\u003e$635m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEBITDA margin\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFree cash to interest\u003c\/td\u003e\n\u003ctd\u003e~40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVolume CAGR (2019–24)\u003c\/td\u003e\n\u003ctd\u003e1.2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapEx\/sales\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;3%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview = Final Product\u003c\/span\u003e\u003cbr\u003ePyxus BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing on this page is the final Pyxus BCG Matrix you'll receive after purchase; no watermarks, no demo placeholders—just a fully formatted, analysis-ready report crafted for strategic clarity and professional use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748411781497,"sku":"pyxusintl-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/pyxusintl-bcg-matrix.png?v=1772207848","url":"https:\/\/growthsharematrix.com\/products\/pyxusintl-bcg-matrix","provider":"Growth Share Matrix","version":"1.0","type":"link"}